As filed with the Securities and Exchange Commission on February 27, 2017

Registration No. 333-__________

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM S-8

REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OF 1933

REVA Medical, Inc.

(Exact name of registrant as specified in its charter)

5751 Copley Drive

San Diego, CA 92111

(Address, including Zip Code, of Principal Executive Offices)

2010 Equity Incentive PLAN
(Full title of the plan)

Regina E. Groves

Chief Executive Officer

5751 Copley Drive

San Diego, CA 92111

(858) 966-3000

(Name, address and telephone number, including area code, of agent for service)

Copy to:

Michael S. Kagnoff, Esq.

DLA Piper LLP (US)

4365 Executive Dr., Suite 1100

San Diego, California 92121

Telephone: (858) 677-1400

Facsimile: (858) 677-1401

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

CALCULATION OF REGISTRATION FEE

(1)  Pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional securities that may be necessary to adjust the number of shares reserved for issuance pursuant to the Registrant’s 2010 Equity Incentive Plan, as amended, by reason of any stock split, stock dividend, or similar adjustment effected without the Registrant’s receipt of consideration that results in an increase in the number of outstanding shares of the Registrant’s common stock.  

(2)  The 1,285,544 shares being registered under the Registrant’s 2010 Equity Incentive Plan, as amended, represent an increase in the number of shares available for issuance under the Registrant’s 2010 Equity Incentive Plan, as amended (the “Plan”), equal to 3% of 42,851,477 shares, the total outstanding shares of the Registrant as of December 31, 2016. This increase was approved by the Company’s Board of Directors on February 9, 2017, in accordance with the provisions of the Plan that provide for an annual increase of up to 3%.

(3)  Estimated solely for the purpose of computing the registration fee pursuant to Rule 457 under the Securities Act and based on the average of the high and low prices per share of the Registrant’s common stock traded in the form of CDIs on the Australian Securities Exchange on February 24, 2017, which average has been adjusted to account for conversion of CDIs into shares of common stock and converted into U.S. dollars based on the prevailing exchange rate on February 24, 2017 for the purposes of calculating the registration fee.

This registration statement shall become effective upon filing in accordance with Rule 462 under the Securities Act.

REGISTRATION OF ADDITIONAL SHARES PURSUANT TO GENERAL INSTRUCTION E

Pursuant to General Instruction E to Form S-8, the Registrant is filing this registration statement with the Securities and Exchange Commission (the “Commission”) to register an additional 1,285,544 shares of common stock under the Registrant’s 2010 Equity Incentive Plan, as amended, pursuant to the provisions of the plan providing for an annual increase in the number of shares of common stock reserved for issuance under such plan of up to 3%. This registration statement on Form S-8 hereby incorporates by reference the contents of the Registrant’s registration statements on Form S-8 filed with the Commission on April 7, 2011 (Registration No. 333-173371), March 2, 2012 (Registration No. 333-179845), February 28, 2013 (Registration No. 333-186966), March 17, 2014 (Registration No. 333-194619), March 30, 2015 (Registration No. 333-203103), and March 10, 2016 (Registration No. 333-210084) as modified or superseded pursuant to Rule 412 under the Securities Act.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 8.Exhibits.

For a list of exhibits, see the Exhibit Index in this Registration Statement, which is incorporated into this Item by reference.

*   *   *

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of San Diego, State of California, on this 27^th day of February 2017.

REVA Medical, Inc.

By:   /s/ Katrina L. Thompson

Katrina L. Thompson
Chief Financial Officer and Secretary

POWER OF ATTORNEY

Each director and/or officer of REVA Medical, Inc. whose signature appears below constitutes and appoints Katrina L. Thompson as such person’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming that said attorney-in-fact and agent or his substitute or substitutes, may lawfully do or cause to be done by virtue of this Power of Attorney.

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the date indicated:

EXHIBIT INDEX

__________________________